![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by Staff Writers Shanghai (AFP) Dec 31, 2020
China has confirmed its first case of a new coronavirus variant that was recently detected in Britain, health officials said. The new strain, which experts say potentially spreads faster than the original variant, has prompted travel restrictions on the UK by more than 50 countries -- including China, where the coronavirus first emerged late last year. The first patient in China with the new variant is a 23-year-old woman from Shanghai who arrived from Britain on December 14, the Chinese Centre for Disease Control said in a research note published Wednesday. She was hospitalised on arrival as she showed mild symptoms. Health experts conducted a genetic sequencing of her test samples on December 24 "due to travel history from the UK and abnormalities in nucleic acid test results"," the China CDC said. The patient was found to have a strain different to those found in Shanghai or Wuhan earlier, and further testing confirmed it was the variant known as B.1.1.7 that has been spreading in the UK since October. Health authorities have carried out contact-tracing, the CDC statement added. China suspended direct flights to and from Britain indefinitely on December 24 because of the new strain. British Prime Minister Boris Johnson has said the new variant "may be up to 70 percent more transmissible than the original version of the disease". But there is no evidence so far to suggest that infection with the new variant is more likely to lead to a severe case of Covid-19 or increase the risk of death.
![]() ![]() Turkey to start using China's Covid-19 vaccine after strong results Istanbul (AFP) Dec 24, 2020 Turkey will receive its first shipment of China's Sinovac coronavirus vaccine within days as preliminary domestic tests showed it was 91% effective, Health Minister Fahrettin Koca said on Thursday. Ankara in the next few days will also sign a deal with Pfizer/BioNTech for 4.5 million doses, with the option to buy 30 million more from the US pharmaceutical giant and its German partner, Koca said Turkey will initially receive three million doses of Sinovac and have the option for 50 million more a ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |